Pharmacology & Pharmaceutics | All Life | Taylor & Francis

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Pharmacology & Pharmaceutics

All Life

The Pharmacology and Pharmaceutics Section of All Life publishes research across the fields of experimental and clinical pharmacology.

In this section of All Life, we consider for publication the latest news on:

Experimental Pharmacology

Clinical Pharmacology



Therapeutic Drug Monitoring

Drug Safety

Drug Design



Molecular Modelling

Drug Targeting

Pharmaceutical Nanotechnology

All Life is linked with the UN’s Sustainable Development Goals. We invite researchers to share their latest research, data and opinions that work towards progressing solutions to Goal 3: Good Health and Well-being.

Meet the Section Editor

Editorial board for All Life

Stefania Nobili, University of Florence, Italy

Dr Nobili is a Research Associate at the Department of Health Sciences, University of Florence, Italy. She received her PharmD degree from the University of Rome ‘La Sapienza’ in 1989, her specialization in Applied Pharmacology from the University of Florence in 1997, and her Ph.D. in Chemotherapy from the University of Milan in 2001. In 2013, she was awarded the Alberico Benedicenti Award for Pharmacology and Toxicology from the Italian Society of Pharmacology. Her research interests are focused on preclinical and clinical pharmacology of anticancer drugs, in particular cancer pharmacogenetics and pharmacogenomics, tumor drug resistance, with emphasis on drugs used in the treatment of gastrointestinal neoplasms.

Publicly Available Data Sharing Policy

All Life authors are required to make supporting data and materials freely available before submission in a suitable repository under any Creative Commons license.

Click below to find out more and understand the steps you need to take before submission.


Why Submit to All Life?

All Life is a fully Open Access journal to serve the ever-growing expansion of multi- and inter-disciplinary research in the life sciences:

  • Unique aims and scope welcoming truly multidisciplinary research in the life sciences (indexed in the Multidisciplinary Sciences JCR category).

  • Supporting the UN's Sustainable Development Goals for positive societal impact, providing a platform for reaching policymakers and professionals who are tackling today’s problems.

  • Pushing the boundaries of science by accepting submissions of negative/null data as well as replication and reproduction studies.

  • Promoting better information sharing through mandating public availability of all data associated with submissions.

  • Rigorous peer review process led by our team of subject experts across specialty sections.

  • Disseminating accessible and trustworthy research that has an impact on all life.

  • Indexed by EBSCOhost, Academic Search Complete, TOC Premier (Table of Contents), OCLC, Arts and Humanities Search, Ovid, Inspec, and Science Citation Index Expanded (Web of Science)

 Submit Now

Good editing leads to a great manuscript

Taylor & Francis offers a full range of pre-submission manuscript preparation services, including English language editing.

Get article alerts

Stay up to date with the latest articles by signing up to receive new content alerts.
Sign up